Exclusive Coverage of the 2019 Academy of Managed Care Pharmacy Annual Meeting

Highlights from the 2019 Academy of Managed Care Pharmacy Managed Care & Specialty Pharmacy Annual Meeting, which took place on March 25-28 in San Diego, CA are available in this newsletter published by The American Journal of Managed Care.

Download PDF: Exclusive Coverage of the 2019 Academy of Managed Care Pharmacy Managed Care & Specialty Pharmacy Annual Meeting

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Exclusive Coverage of the 2019 Academy of Managed Care Pharmacy Annual Meeting

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

GLP-1 Plus Glucagon: The Mechanistic Case for Dual Receptor Agonism in Obesity and MASH

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

Almost No Public Awareness of Lp(a), Elevated CVD Risk in the US: Katherine Wilemon

Avoiding TNF Cycling: When to Switch Drug Classes in Rheumatoid Arthritis

Rituximab Matches Ocrelizumab in Head-to-Head MS Trial

A Look at PBM Reform and Transparency: Payer, Provider and Patient Impact

Exclusive Coverage of the 2019 Academy of Managed Care Pharmacy Annual Meeting

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

GLP-1 Plus Glucagon: The Mechanistic Case for Dual Receptor Agonism in Obesity and MASH

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

Almost No Public Awareness of Lp(a), Elevated CVD Risk in the US: Katherine Wilemon

Avoiding TNF Cycling: When to Switch Drug Classes in Rheumatoid Arthritis

Rituximab Matches Ocrelizumab in Head-to-Head MS Trial